In the present study we investigated whether basic fibroblast growth factor (bFGF) plays a role in the proliferative response of smooth muscle cells (SMCs) (PDGF).1 Recently, however, Fingerle et a14 have shown that smooth muscle replication after balloon catheter denudation of the rat carotid artery occurs even in the absence of platelets. These data suggested that PDGF from platelets might not play a major role in the stimulation of smooth muscle replication seen after vascular injury. Furthermore, a comparison of two methods of experimental arterial injury showed that smooth muscle replication appears to correlate with medial damage rather than endothelial loss or adherence of platelets.5 6 These latter data led us to consider the possibility that injury-induced release of endogenous mitogens might play a pivotal role in the subsequent
In the present study we investigated whether basic fibroblast growth factor (bFGF) plays a role in the proliferative response of smooth muscle cells (SMCs) to denuding injury. Rat carotid smooth muscle was found to express the mRNA for bFGF, and bFGF protein was found to be present in rat aorta by immunoblot analysis. Systemically administered bFGF was a potent mitogen for vascular SMCs in arteries denuded with a balloon catheter, increasing replication from 11.5% in controls to 54.8%. Denudation with a device (filament loop), which causes only minimal damage to medial SMCs, showed a similar increase in replication (1.3% versus 43.3%) after bFGF infusion. In unmanipulated vessels, however, SMCs were unresponsive to infused bFGF. Infusion of a "lmitotoxin" (bFGF conjugated to saporin) caused a greater than 50% decrease in the number of viable SMCs in the arterial wall after balloon injury. Prolonged administration of bFGF (12 Akey event in arteriosclerosis is the development of an intimal lesion with subsequent narrowing of the vessel lumen.' Although many factors are believed to be involved in this process,23 much attention has focused on plateletderived growth factor (PDGF).1 Recently, however, Fingerle et a14 have shown that smooth muscle replication after balloon catheter denudation of the rat carotid artery occurs even in the absence of platelets. These data suggested that PDGF from platelets might not play a major role in the stimulation of smooth muscle replication seen after vascular injury. Furthermore, a comparison of two methods of experimental arterial injury showed that smooth muscle replication appears to correlate with medial damage rather than endothelial loss or adherence of platelets.5 6 These latter data led us to consider the possibility that injury-induced release of endogenous mitogens might play a pivotal role in the subsequent Lindner et al Basic FGF and Vascular Injury 107
The tissue was then homogenized in 3 ml cell lysis buffer containing 50 mM Tris-HCl (pH 7.5), 1% Nonidet P-40, 2 mM EDTA, 2 mM EGTA, 0.5% deoxycholate, 1 with a protein concentration of 1.2 mg/ml. Each rat received 120 ,g bFGF diluted in 2 ml saline. Control infusions contained equal amounts of vehicle diluted in 2 ml saline. The infusion was started with a bolus injection of 30 gg bFGF given intra-arterially followed by a continuous infusion over an 8-hour period through a catheter placed into the aortic arch via the right axillary artery. The remainder of the bFGF (90 ,ug) was administered over an 8-hour time period. In control rats, equal amounts of vehicle were infused in the same fashion. At 24, 32, and 40 hours after the infusion was started, the animals were injected with tritiated thymidine (50 ,uCi/100g body wt, 6.7 mCi/ mmol, New England Nuclear, Boston). One hour before the rats were killed, Evans blue (0.5 ml, 5% in saline) was injected intravenously to mark the stilldenuded surface, and the animals were perfusionfixed 41 hours after the start of the bFGF infusion. The technique for perfusion-fixing arteries at physiological flow and pressure has been described elsewhere. 16 Briefly, the rats were killed with an overdose of sodium pentobartital, a catheter was placed in the abdominal aorta, and the animals were fixed with 4% paraformaldehyde in phosphate buffer (0.1 M, pH 7.3) at physiological pressure and flow for 4 minutes. Segments from the denuded carotid arteries were embedded in paraffin, and from each segment at least four cross sections were cut 100 gtm apart from each other. The sections were then processed for autoradiography (as described below) and counterstained with hematoxylin. Segments of the unmanipulated right carotid artery were processed in an identical way to determine the effect of bFGF on uninjured tissue.
The identical experiment was carried out in another set of rats whose left carotid arteries were denuded of endothelium by a less traumatic technique by using a filament loop, which removes all the endothelium but does not significantly damage the underlying tunica media. The detailed procedure is described elsewhere. 
Response of Intimal Smooth Muscle Cells to Basic Fibroblast Growth Factor
The left carotid arteries of the rats were denuded by balloon catheterization, and within a few weeks these vessels had developed an extensive intimal thickening.
Six weeks after denudation, the proliferation of the intimal smooth muscle had slowed down dramatically.17,18 At this time, any stimulation of smooth muscle replication would be detectable, and therefore bFGF (120 kg) or vehicle was infused 6 weeks after denudation by the identical protocol as described above.
Segments of the left carotid artery that were still deendothelialized (with smooth muscle cells forming the luminal surface) were identified by their permeability for Evans blue. These segments were processed for cross sections embedded in paraffin.
Autoradiography
For autoradiography, the preparations were dipped in Kodak NTB-2 emulsion and exposed for 2 weeks.
The slides were then developed, stained with hematoxylin, and mounted under coverslips. On cross sections, the total number and the number of labeled medial or intimal SMCs were counted.
[3H]Thymidine indexes were obtained by dividing the number of labeled cells by the total number of cells.
Mitotoxin Experiment
The interaction of bFGF with its receptor on SMCs was studied in an additional experiment with bFGF conjugated to the ribosome-inactivating protein saporin-6.19 Saporin itself is not toxic to cells. '9 However, if saporin is conjugated to bFGF, it is taken up by cells that express the bFGF receptor and then it is a potent toxin that causes cell death. In this experiment, the left carotid arteries of two groups of rats were denuded of endothelium with a balloon catheter and an equimolar concentration of bFGF (120 kg) conjugated to saporin or unconjugated bFGF and saporin were infused intra-arterially, as described above.
Intimal Thickening Formation
The left common carotid artery was denuded of endothelium with a balloon catheter, and starting at the day of denudation, the rats received injections of either 12 kug bFGF or an equal amount of vehicle via tail vein daily for 2 weeks. Evans blue staining was used to mark the still-denuded area. A central portion of the denuded carotid artery was embedded in paraffin, and four cross sections per segment (each 100 ,um apart) were cut and counterstained with hematoxylin. Intimal cross-sectional areas were measured using a digitizing pad (GTCO Corp., Rockville, Md.), a camera lucida (Leitz, Wetzlar, FRG), and a software package (IMAGE MEASURE, Microscience, Seattle).
The number of intimal cells was determined by counting nuclear profiles of intimal cells. This value 6 .0kb-FIGURE 1. Northern blot from normal rat carotid artery demonstrates presence of mRNA for basic fibroblast growth factor. The cDNA probe hybridized to a single 6.0-kb band.
was then expressed as cells per unit area of intima (i.e., cells per square millimeter).
Results

Endogenous Basic Fibroblast Growth Factor in the Vessel Wall
The synthesis of bFGF in the rat arteries was demonstrated by Northern and immunoblot analysis. Pooled mRNA from rat carotid arteries showed a single transcript of 6.0 kb when hybridized with the cDNA for rat bFGF (Figure 1) . Extracts of deendothelialized arteries were also run on a polyacrylamide gel, blotted onto nitrocellulose, and stained with an antibody raised against human recombinant bFGF. As shown in Figure 2, Figure 3) . The proliferative response of smooth muscle was also studied in carotid arteries of rats for which the endothelium was denuded by a technique that causes no significant damage of the underlying tunica media (filament loop).5,16 In this experiment, infusion of bFGF (120 kg) again caused a highly significant increase in SMC proliferation (1.3% versus 43.3%, Figure 3) . It was interesting to note that even though the basal levels of proliferation after the two injuries were markedly different, the administration of bFGF stimulated the SMCs in both injury models to the same high level (54.8% not significantly different from 43.3%). In the (Figure 3 ). An alternative approach in understanding the role of bFGF in the proliferation of SMCs after injury of the vascular wall would be to use a receptor antagonist. Because such an antagonist to bFGF is currently not available, we chose to use a mitotoxin made by conjugating bFGF to the ribosome-inactivating protein saporin.'9 This mitotoxin will compete for receptor binding of bFGF in cells and will mediate cell death after internalization. Consequently, if arterial cells bind bFGF after injury, then we might expect to see widespread cell death after administration of this mitotoxin. In such an experiment, the mitotoxin (120 gg bFGF conjugated to an equimolar amount of saporin) was given to rats immediately before balloon injury of the carotid artery, while control animals received the same amount of unconjugated bFGF and saporin. An obvious loss of medial SMCs in the denuded arteries was observed in morphological sections (Figure 4 ) such that certain areas were completely devoid of SMCs, while others showed loss of medial cells only in the more luminal cell layers. Counts of cell profiles showed a loss of more than 53% of smooth muscle in these arteries ( Figure 5 ). The majority of the surviving medial SMCs were located in the cell layers adjacent to the adventitia. No loss of SMCs was observed in unmanipulated arteries with intact endothelium (Figure 5 ).
In the studies described above, we have shown bFGF to be a potent mitogen for medial SMCs. However, data from this and other laboratories have demonstrated that cells from intimal lesions are capable of sustained proliferation17'18 in the absence of platelets and that they have unique attributes not possessed by medial SMCs. Thus, the possibility exists that intimal smooth muscle might respond differently to bFGF. We therefore investigated whether bFGF influenced replication of intimal smooth muscle. This was carried out by infusing bFGF (120 jig) into rats whose carotid arteries were denuded with a balloon catheter 6 weeks before the infusion. This time point was chosen because 6 weeks after balloon injury a substantial intimal thickening has formed, yet the smooth muscle replication is low,'s and any increase in replication induced by exogenous bFGF would therefore be readily detectable. In these animals, replication of the intimal SMCs from the deendothelialized segment of the carotid artery was significantly increased by the administration of bFGF as compared with cells in arteries from animals receiving vehicle (6.9% versus Medial SMCs bFGF group versus 4,313 +208 cells/mm2 in controls, mean+SEM, n=6 animals in each group). This suggested that the increased intimal thickening in the bFGF-treated animals was due to an increase in cell number and not due to an increase in extracellular matrix production.
Discussion After a denuding arterial injury, the subsequent proliferation of SMCs in injured vessels was widely believed to be the result of mitogen release from the adhering platelets. A previous study from this laboratory addressed this question by investigating SMC proliferation in rats that were depleted of platelets by injection of an anti-platelet antibody.4 Balloon catheter denudation of the carotid artery from these thrombocytopenic animals caused a significantly elevated but equal response in SMC proliferation as found in animals with a normal platelet count. Modulation of SMC proliferation, however, was achieved in another study,5,16 for which carotid arteries were denuded of endothelium by a gentler technique (filament loop denudation) that causes only minimal trauma in the underlying tunica media. Despite the fact that this denudation exposed a thrombogenic surface and large platelet thrombi formed, the SMC~~~~~~~~~~~~~~~~~~~~~1 Evidence for a role of bFGF in SMC proliferation after arterial injury also comes from the experiment in which bFGF was conjugated to saporin. This mitotoxin, when infused in balloon catheter-denuded vessels, caused a significant decrease in the number of SMCs in these arteries, which reflects widespread cell death. Saporin not conjugated to bFGF was not toxic to SMCs, which agrees with previous data showing that saporin itself cannot readily be transported into a cell. 19 When bound to bFGF, however, the toxin is carried into the cell via a bFGF receptor-mediated pathway, leading to cell death. These data provide evidence that SMCs of the arterial wall readily bind and internalize bFGF. It was of interest to note that the mitotoxin did not influence SMCs in unmanipulated carotid arteries. This finding agrees with data shown in Figure 3 , which shows that bFGF did not stimulate the SMCs from uninjured arteries. As discussed above, one explanation is that an intact endothelium acts as a permeability barrier to both bFGF and the bFGF-saporin conjugate, in which case the underlying SMCs are never exposed to these added factors.
A considerable amount of literature has shown that SMCs from an intimal lesion have a different morphology23 and physiology. 24, 25 This prompted us to determine the effect of bFGF on intimal smooth muscle. In this study, we found that bFGF was mitogenic for intimal cells, and yet in these same arteries, no increase in medial SMC proliferation was observed. Because the intimal thickening was not covered with endothelium and the majority of replicating SMCs was found in the cell layers close to the luminal surface, these data suggest that a concentration gradient exists across the vessel wall for the infused bFGF and that the medial cells are never exposed to the exogenously added mitogen. Similarly, medial smooth muscle was not stimulated by bFGF in unmanipulated arteries with an intact endothelium.
In a recent study,26 we showed that prolonged administration of bFGF promoted total regrowth of vascular endothelium in situations were regrowth is severely limited. One possible application of these data is that bFGF might have the potential to induce endothelial regrowth in a clinical setting. The present data show that bFGF would not only stimulate replication of SMCs but would also cause a significant increase in the growth of intimal lesions. Therefore, any beneficial effect of bFGF with regard to endothelial cell growth would be outweighed by the increase in intimal lesion size. Future experiments will need to investigate whether the dose sensitivity of bFGF for endothelium and smooth muscle might influence these cells with different efficiency.
